CHICO, Calif. - Enloe Medical Center has been utilizing monoclonal antibody infusion treatments to reduce the severity of COVID-19 symptoms and avoid hospitalizations in both vaccinated and unvaccinated patients.
This week, Enloe was notified that the Federal Department of Health and Human Services assumed the role of allocating monoclonal antibody infusion supplies.
The hospital was also notified that rationing of the treatment is imminent and it may not receive the number of treatments requested.
Since the treatments may become scarce in the weeks and months following, Enloe Hospital says the treatment can no longer be relied upon as people’s first defense against serious illness, hospitalization, or long-term health consequences.
Even with this therapy, hospitalizations of COVID-19 positive patients are continuing to increase, according to Enloe.
As of Sept. 13, the hospital has seen its highest number of ventilated COVID-19 patients to date.
Over the last seven days, Enloe Medical Center has cared for an average of 72.2 COVID-positive patients daily while the daily average of critical care patients is 11.7.
Of those critical care patients, an average of 5.4 requires ventilation.
These numbers are specific to patients that are seen in the hospital’s Emergency Department or Prompt Care that does not require hospital admission.
Of those, more than 50% are between the ages of 20 and 50 years old, the majority of hospitalized COVID-positive patients, including those in critical care requiring ventilation, are unvaccinated, Enloe stated.
The hospital says it has reached a tipping point.
“Vaccination remains the most effective method of preventing serious illness and hospitalization,” Enloe said.
— Enloe Medical Center (@Enloe) September 13, 2021